HALO · NASDAQ · Healthcare · Biotechnology

Halozyme Therapeutics

—近一月
价格暂不可用
  • 52周区间61.23–116.85
  • 市盈率32.50
  • 市值124.68亿

最新消息

加载中...

简介

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables ...

halozyme.com